官方服务：
资源简介：
CRC samples for FOLFOX therapy prediction
应用场景：
创建时间：
2011-11-21
相关数据集
MAQC-II Project: human breast cancer (BR) data set
The human breast cancer (BR) data set (endpoints D and E) was contributed by the University of Texas M. D. Anderson Cancer Center (MDACC, Houston, TX, USA). Gene expression data from 230 stage I-III b
NIAID Data Ecosystem100
Molecular subtyping of “double negative” MIBC
Identifying patients that benefit from cisplatin-based adjuvant chemotherapy is a major issue in the management of muscle-invasive bladder cancer (MIBC). The purpose of this study is to correlate “lum
NIAID Data Ecosystem30
Supplementary Material for: Circulating tumor DNA testing overcomes limitations of comprehensive genomic profiling from tumor tissue
The “liquid biopsy” is an established technique for examining circulating tumor DNA (ctDNA) from a routine blood draw and detecting actionable biomarkers. Nonetheless, ctDNA testing is rarely utilized
NIAID Data Ecosystem10
Additional file 8 of Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer
Additional file 8: Table S5. Clinical and genomic features of 85 samples from Cohort II.
Figshare2024-02-20 更新50
DataSheet_1_Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients.docx
BackgroundBiomarkers predicting treatment response may be used to stratify patients with pancreatic ductal adenocarcinoma (PDAC) for available therapies. The aim of this study was to evaluate the asso
NIAID Data Ecosystem20
